1. Zhang X, Tan Y, Ling Y, Lu G, Liu F, Yi Z, et al. Viral and host factors related to the clinical outcome of COVID-19. Nature. 2020; 583:437–40.
2. The Severe Covid-19 GWAS Group. Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020; 383:1522–34.
3. Wright JT, Grange DK, Fete M. Hypohidrotic Ectodermal Dysplasia. 2003 Apr 28 [updated 2017 Jun 1]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.
4. Trzeciak WH, Koczorowski R. Molecular basis of hypohidrotic ectodermal dysplasia: an update. J Appl Genet. 2016; 57:51–61.
5. Wohlfart S, Hammersen J, Schneider H. Mutational spectrum in 101 patients with hypohidrotic ectodermal dysplasia and breakpoint mapping in independent cases of rare genomic rearrangements. J Hum Genet. 2016; 61:891–7.
6. Dietz J, Kaercher T, Schneider AT, Zimmermann T, Huttner K, Johnson R, et al. Early respiratory and ocular involvement in X-linked hypohidrotic ectodermal dysplasia. Eur J Pediatr. 2013; 172:1023–31.
7. Li S, Zhou J, Zhang L, Li J, Yu J, Ning K, et al. Ectodysplasin A regulates epithelial barrier function through sonic hedgehog signalling pathway. J Cell Mol Med. 2018; 22:230–40.
8. Clarke A, Phillips DI, Brown R, Harper PS. Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child. 1987; 62:989–96.
9. Blüschke G, Nüsken KD, Schneider H. Prevalence and prevention of severe complications of hypohidrotic ectodermal dysplasia in infancy. Early Hum Dev. 2010; 86:397–9.
10. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323:1239-1242.
11. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020; 382:1663-1665.
12. Li W, Zhang B, Lu J, Liu S, Chang Z, Peng C et al. The characteristics of household transmission of COVID-19. Clin Infect Dis. 2020; 71:1943-6.
13. Lapuente D, Maier C, Irrgang P, Hübner J, Peter AS, Hoffmann M, et al. Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2021; 40:751–759.
14. Schuh W, Baus L, Steinmetz T, Schulz SR, Weckwerth L, Roth E, et al. Cell-based SARS-CoV-2 spike surrogate blocking assay (SUBA). Eur J Immunol. under review
15. Peter AS, Roth E, Schulz SR, Fraedrich K, Steinmetz T, Damm D, et al. A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model. https://www.biorxiv.org/content/10.1101/2021.04.16.440101v1 (Preprint)
16. Al-Jassim AH, Swift AC. Persistent nasal crusting due to hypohidrotic ectodermal dysplasia. J Laryngol Otol. 1996; 110:379–82.
17. Couzin-Frankel J. The long haul. Science 2020; 369:614–7.
18. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27:601–15.
19. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Res Sq. 2021 Mar 1;rs.3.rs-266574 (Preprint), doi: 10.21203/rs.3.rs-266574/v1
20. Nehme M, Braillard O, Alcoba G, Aebischer Perone S, Courvoisier D, Chappuis F, et al. COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med. (online first) 8 December 2020, doi: 10.7326/M20–5926
21. Halpin S J, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2020; 93: 1013–22.
22. Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. ‚Long-COVID‘: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. (online first) 10 November 2020, doi: 10.1136/thoraxjnl-2020–215818
23. Rubin R. As their numbers grow, COVID-19 “Long Haulers” stump experts. JAMA 2020; 324:1381–3.
24. Chien Yin GO, Siong-See JL, Wang ECE. Telogen Effluvium - a review of the science and current obstacles. J Dermatol Sci. 2021; 101:156–63.
25. Moreno‐Arrones OM, Lobato‐Berezo A, Gomez‐Zubiaur A, Arias‐Santiago S, Saceda‐Corralo D, Bernardez‐Guerra C. SARS‐CoV‐2‐induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol. 35:e181-3.
26. Schneider H, Hammersen J, Preisler-Adams S, Huttner K, Rascher W, Bohring A. Sweating ability and genotype in individuals with X-linked hypohidrotic ectodermal dysplasia. J Med Genet. 2011; 48:426–32.
27. Burger K, Schneider AT, Wohlfart S, Kiesewetter F, Huttner K, Johnson R, et al. Genotype-phenotype correlation in boys with X-linked hypohidrotic ectodermal dysplasia. Am J Med Genet A. 2014; 164:2424–32.